|
|
 |
|
Viewing report
|
|
|
|
U.S. Medical Imaging Industry Outlook
Frost & Sullivan, April 2002
Aging Population Spurs Demand for Medical Imaging
As the population of elderly people in America continues to grow, so will
demand for a wide range of medical imaging modalities. Meanwhile, advances
in many technologies, such as x-ray mammography and positron emission
tomography (PET), will provide doctors with better resolution and faster
scanning, encouraging their use in diagnostics. The greatest challenge for
market participants will be to overcome the high costs of many imaging
modalities, which force insurers to restrict reimbursement.
This study analyzes the markets for a full range of medical imaging
technologies, including x-ray mammography, magnetic resonance imaging (MRI)
PET, gamma cameras, digital radiography, computed tomography (CT), picture
archiving and communications, osteoporosis diagnostic imaging equipment, 3D
imaging, and ultrasound equipment. By pinpointing market drivers and
restraints and by offering expert revenue forecasts, this study gives its users
an in-depth overview of the field.
Dual-Function Machines Define Course for Research and Development
Combined or dual-function modalities that combine structural and molecular
imaging will be the wave of the future, says the study’s author. For example,
the PET/CT segment, which was launched in 2001, has already surpassed
expectations that were set for that hybrid technology before its introduction.
Nevertheless, meeting the high costs of developing combination products will
be difficult. Break-throughs in MRI, digital radiography, and PET/CT are
extremely expensive to finance, states the analyst. Companies without
effective long-term strategies for managing research and development costs
could find themselves acquired or edged out of the market. This study
examines challenges and provides strategic recommendations, helping your
firm optimize its resources.
Low Reimbursement Rates Threaten Industry Growth
Low reimbursement rates have become a major challenge, not only for
end users, but for manufacturers as well. Radiology administrators agree that
imaging reimbursements for many procedures are inadequate given the
expense of the equipment and the expertise required to create and interpret
results, according to the author.
Lack of adequate compensation is a concern for all industry participants, as
many healthcare centers are delaying or cancelling purchases of high-priced
items. Until the financial rewards for imaging services are increased
substantially and definitively, low reimbursement will be the foremost hurdle
for manufacturers, says the author. This study highlights potential problems,
enabling your company to anticipate and overcome obstacles that may
lay ahead.
|
|
|
|
